Tony Reid

Tony Reid

Company: EpicentRx

Job title: Chief Executive Officer


Exploring the Development of RRx-001: the NLRP3 Small Molecule Inhibitor for a Variety of Inflammatory Diseases 9:30 am

Understanding the mechanism of action and preclinical data for the therapeutic candidate Highlighting key formulation and delivery considerations to be on-target and measuring off-target effects Identifying the next steps for the therapeutic candidateRead more

day: Conf Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.